Alvesco® (ciclesonide) Inhalation Aerosol has small particles of asthma medicine that are designed to reach deep into the airways — to deliver asthma medicine where it may help to reduce asthma inflammation

Save with our Alvesco® Savings Card!

Download the Alvesco (ciclesonide) Inhalation Aerosol Savings Card, and you may reduce your co-pay to as little as $17* on each Alvesco prescription fill. Just present your Alvesco Savings Card at the pharmacy for a co-pay reduction of up to $75. That could add up to $900 of savings every year*!

Download the Card

Terms and conditions apply

Alvesco is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and adolescent patients 12 years of age and older.

Important Limitations of Use:

  • Alvesco is NOT indicated for the relief of acute bronchospasm
  • Alvesco is NOT indicated for children under 12 years of age

*Subject to eligibility rules; restrictions apply. Not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D and Medicare Advantage), TriCare, CHAMPUS, or any other local, state or federal healthcare programs, including state prescription drug assistance programs and the La Reforma de Salud program in Puerto Rico.


  1. Alvesco® Inhalation Aerosol Prescribing Information. Marlborough, United Kingdom: Sunovion Pharmaceuticals Inc.; January 2013.
  2. Newman S, Salmon A, Nave R, Drollman A. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma. Respiratory Medicine. 2006;100:375-384.